VYGR Voyager Therapeutics Inc
Company Analysis
Latest News
🟢 Voyager Therapeutics is trading 19.54% up in after-hours trading with no clear company-specific explanation
Voyager Therapeutics is trading at $2.08, up 19.54% in after-hours trading; no clear company-specific announcement was identified to explain the rise. - The...
🟢 Voyager Therapeutics is trading 10% up in after-hours trading
Voyager Therapeutics is trading at $1.91, up +9.78% in after-hours trading, with no clear company-specific announcement or news identified to explain the...
🔴 Voyager Therapeutics is trading 5% down on October 23, 2026, amid broad market and biotech declines
Voyager Therapeutics is trading at $1.76, down 5.11% in live trading on October 23, 2026, amid broader risk-off sentiment; no clear company-specific...
🔴 Voyager Therapeutics is trading 10% down today amid broad market weakness
Voyager Therapeutics is trading at $1.81, down 10.40%, alongside broad market weakness. - The supplied alert reports Nasdaq down 2.19% and the S&P 500 down...
🔴 Voyager Therapeutics is trading 6% down today amid Nasdaq and S&P 500 declines
Voyager Therapeutics is trading at $1.90, down 5.94% on October 22, in line with broad market weakness. - The Nasdaq was down 2.19% and the S&P 500 down...
🔴 Voyager Therapeutics is trading 6% down with no confirmed catalyst identified
Voyager Therapeutics is trading at $2.06, down 5.71%, with no confirmed catalyst identified. - Voyager announced Robin Swartz as president, effective October...
Voyager Appoints Robin Swartz as President, Outlines CEO Succession Plan for Q1 2027
Voyager Therapeutics has appointed Robin Swartz, the company's Chief Business Officer and Chief Operating Officer, to the role of President, effective October...
🔴 Voyager Therapeutics is trading 6.4% down in pre-market with no confirmed catalyst identified
Voyager Therapeutics is trading at $2.05, down 6.40% in pre-market; no confirmed catalyst for the move was identified. - On October 21, Voyager Therapeutics...
🔴 Voyager Therapeutics is trading 8.66% down today in after-hours trading — catalyst unclear
Voyager Therapeutics is trading at $2.00, down 8.66%, in after-hours trading; the catalyst remains unclear. - No company-specific announcement dated October 20...
🟢 Voyager Therapeutics is trading 11% up today amid biotech gains; no clear company catalyst found
Voyager Therapeutics is trading at $2.27, up +10.77%, amid biotech-sector strength. - Biotech rose 2.10%, less than Voyager Therapeutics’ advance. - No clear...
🟢 Voyager Therapeutics is trading 6.34% up on October 20, 2026, as biotech sector rises about 2.1%
Voyager Therapeutics is trading at $2.18, up 6.34%, with biotech-sector strength the clearest available context for the move. - The supplied market context...
🟢 Voyager Therapeutics is trading 5% up on October 19, 2026, amid a biotech-sector rally
Voyager Therapeutics is trading at $2.00, up 5.00%, during the October 19 session, in line with a biotech-sector rally; no clear Voyager-specific announcement...
🔴 Voyager Therapeutics is trading 5.6% down today amid biotech-sector and broader-market weakness
Voyager Therapeutics is trading at $1.95, down -5.58%, in line with weaker biotech-sector sentiment and broader-market declines. - The provided context shows...
🟢 Voyager Therapeutics is trading 8.5% up in after-hours trading
Voyager Therapeutics is trading at $2.23, up 8.46%, after hours, with no clear company-specific announcement identified to explain the move. - The shares...
🔴 Voyager Therapeutics is trading 5.6% down today amid inflation-driven rate-hike concerns
Voyager Therapeutics is trading $2.03, down 5.58%, amid broader-market weakness; no clear company-specific announcement explaining the October 14 decline was...
🔴 Voyager Therapeutics is trading 5% down
Voyager Therapeutics is trading 5.07% down at $2.15; biotech-sector weakness is relevant context, but no company-specific cause has been confirmed for the...
🟢 Voyager Therapeutics is trading 5% up in pre-market
Voyager Therapeutics is trading 5.23% up in pre-market at $2.39 on October 13, with no clearly confirmed company-specific announcement explaining the move. -...
🟢 Voyager Therapeutics rises 5.7% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Voyager Therapeutics is trading 5% down amid biotech sector weakness
Voyager Therapeutics is trading at $2.35, down 5.06%, amid biotech sector pressure. - The provided sector context reports XBI down 2.04%, pointing to sector...
🔴 Voyager Therapeutics is trading 5% down
Voyager Therapeutics is trading 5.05% down now at $2.54, with no company-specific announcement or catalyst identified in available news and company release...